Induction of antibodies against GD3 ganglioside in melanoma patients by vaccination with GD3-lactone-KLH conjugate plus immunological adjuvant QS-21.
about
B-Raf specific antibody responses in melanoma patientsDesign and synthesis of potent Quillaja saponin vaccine adjuvantsPreclinical evaluation of the synthetic adjuvant SQS-21 and its constituent isomeric saponins.Metastatic melanomas express inhibitory low affinity fc gamma receptor and escape humoral immunity.On the power of chemical synthesis: immunological evaluation of models for multiantigenic carbohydrate-based cancer vaccines.Toward optimized carbohydrate-based anticancer vaccines: epitope clustering, carrier structure, and adjuvant all influence antibody responses to Lewis(y) conjugates in miceHuman monoclonal antibodies to sialyl-Lewis (CA19.9) with potent CDC, ADCC, and antitumor activityThe prioritization of cancer antigens: a national cancer institute pilot project for the acceleration of translational research.Recent Development in Carbohydrate Based Anti-cancer Vaccines.Triterpenoid saponins from the roots of Acanthophyllum gypsophiloides Regel.Conjugation of a self-antigen to papillomavirus-like particles allows for efficient induction of protective autoantibodies.Carbohydrate vaccines as immunotherapy for cancer.Cross-presentation of disialoganglioside GD3 to natural killer T cells.Chemical Synthesis of GM2 Glycans, Bioconjugation with Bacteriophage Qβ, and the Induction of Anticancer Antibodies.Chemical glycosylation in the synthesis of glycoconjugate antitumour vaccines.Natural and synthetic saponin adjuvant QS-21 for vaccines against cancer.Evaluation of widely consumed botanicals as immunological adjuvantsThe known immunologically active components of Astragalus account for only a small proportion of the immunological adjuvant activity when combined with conjugate vaccines.Synthesis of QS-21-xylose: establishment of the immunopotentiating activity of synthetic QS-21 adjuvant with a melanoma vaccine.Immunotherapy for cancer: synthetic carbohydrate-based vaccines.Recent development in carbohydrate-based cancer vaccines.Neuroendocrine cancer vaccines in clinical trials.Carbohydrate-based cancer vaccines: target cancer with sugar bullets.A cancer vaccine based on fluorine-modified sialyl-Tn induces robust immune responses in a murine model.Synthesis and Evaluation of Glycoconjugates Comprising N-Acyl-Modified Thomsen-Friedenreich Antigens as Anticancer Vaccines.Bioengineering of surface GD3 ganglioside for immunotargeting human melanoma cells.Phase I trial of a bivalent gangliosides vaccine in combination with β-glucan for high-risk neuroblastoma in second or later remission.Synthesis of an S-Linked α(2→8) GD3 Antigen and Evaluation of the Immunogenicity of Its Glycoconjugate.
P2860
Q24794587-7612738D-5BCE-42E9-AF2A-6E7D8961EA6CQ33645835-22B76DEF-2AC7-4951-B6EE-1265FD84F9F4Q33899683-8D6D0591-0C04-45B7-85EB-893B289F8B5FQ34002125-871A81AB-96DE-4683-965D-350621139576Q34160588-94688C73-4E64-4A46-B309-640F8D28BEA4Q34719681-71A404C4-AD99-469E-A93C-7967F65E774EQ34782050-3F928F5F-59E9-4B37-916B-48B54F77764CQ35000726-15FD1894-B8E5-48D6-B844-50F715EA85B3Q35854131-0C0FB9FB-356F-4259-830F-4E022C8767E5Q36073600-FBAEE309-3219-4CF8-9AFC-DFA1EDAAC2C9Q36167475-61B81D09-E274-4176-A1C6-F6A8E99F6BB0Q36201691-F4A2491F-322D-4DE0-9E74-32773B6A60DFQ36376637-AA99A8AB-8612-46C5-BAD2-CD3D95C7B9F9Q36501284-18D63337-08F1-42A3-8367-B6BC8E7DF968Q36802325-B446CDBD-A2C6-4459-AB6A-E920F099F5D3Q36856279-200B0C84-24DF-4893-86E7-74AA8DB78713Q36932370-D48D3F31-195C-4801-81DC-C511FF5BD3BEQ37011520-8E52BEC2-FCBB-4AAB-B494-D62BF65B78C2Q37014879-E077D140-3A85-405A-AF42-9B17A4510E22Q37453814-4A6EF159-9912-4DAA-91D8-A6936B563165Q37455940-7712FD7E-59A8-4661-A641-8D20BD66A48FQ37892589-2EC8DD3D-DD1F-4D4C-A441-D71DA9D3D7F2Q38016342-5C534068-7194-4530-9618-F935A2EB6F95Q38767397-6BB66E9D-5443-44DF-BF45-DE83B533E755Q38778469-F83649D4-CF4D-4606-81C9-5512814BB8D9Q40572917-8967F121-7453-4B74-B099-68B429A9D78CQ41394300-6F94000D-A78F-4F90-98B9-F4F6D3068BF6Q51098501-42F3BCF3-90A2-40F5-BC8F-4F3A3DD45FA7
P2860
Induction of antibodies against GD3 ganglioside in melanoma patients by vaccination with GD3-lactone-KLH conjugate plus immunological adjuvant QS-21.
description
2000 nî lūn-bûn
@nan
2000年の論文
@ja
2000年学术文章
@wuu
2000年学术文章
@zh-cn
2000年学术文章
@zh-hans
2000年学术文章
@zh-my
2000年学术文章
@zh-sg
2000年學術文章
@yue
2000年學術文章
@zh
2000年學術文章
@zh-hant
name
Induction of antibodies agains ...... immunological adjuvant QS-21.
@en
type
label
Induction of antibodies agains ...... immunological adjuvant QS-21.
@en
prefLabel
Induction of antibodies agains ...... immunological adjuvant QS-21.
@en
P2093
P2860
P1476
Induction of antibodies agains ...... immunological adjuvant QS-21.
@en
P2093
C Musselli
G Ragupathi
P O Livingston
P2860
P304
P356
10.1002/(SICI)1097-0215(20000301)85:5<659::AID-IJC11>3.0.CO;2-5
P577
2000-03-01T00:00:00Z